EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effectiveness of Dexmedetomidine and Sufentanil in Preventing Adverse Reactions to Carboprost Tromethamine During Cesarean Section with Noninvasive Cardiac System Monitoring

Jing Li, Bo Xiang, Xiaofeng Lei, Jin Yu

Clinical Drug Investigation · 2026

DOI: 10.1007/s40261-026-01547-x ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Drug Investigation, 2026. Verfasst von Jing Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Chongqing Health Center for Women and Children,, Women and Children's Hospital of Chongqing Medical University, No. 120…. Hauptthemen laut MEDLINE: Cesarean Section, Sufentanil, Dexmedetomidine, Carboprost. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Institutional Research Grants from Chongqing Health Center for Women and Children, Chongqing Traditional Chinese Medicine Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau, National Key Clinical Specialty Discipline Construction Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Carboprost tromethamine is commonly used to prevent or treat postpartum hemorrhage during cesarean section but causes frequent side effects. This study aimed to compare dexmedetomidine and sufentanil for preventing these side effects and assess hemodynamic stability. METHODS: This is a single-center randomized controlled trial. Parturients undergoing elective cesarean section were randomized to Group D (dexmedetomidine intravenously), Group S (sufentanil intravenously), and Group C (saline intravenously). Carboprost tromethamine 250 µg was intrauterine injected after delivery. The incidence of complications, Ramsay sedation scores, and noninvasive cardiac system-derived hemodynamic parameters were analyzed. The primary endpoint is dexmedetomidine or sufentanil could relieve the nausea and vomiting caused by carboprost tromethamine. RESULTS: A total of 152 subjects were included in the analysis. Both Groups D and S had significantly fewer intraoperative nausea and vomiting episodes (Group D 16% vs Group S 19.2% vs Group C 76%, P < 0.001) and higher Ramsay scores (P < 0.001) compared with Group C. Group C showed significant increases in mean arterial pressure and respiratory rate (P < 0.05). Heart rate in Group D was significantly lower than in Group C (P < 0.05). The total peripheral resistance was significantly lower in Group S at T2-T5 (from 2 minutes post-carboprost tromethamine until the end of surgery) and in Group D at T2-T4 (2, 5, and 10 minutes post-carboprost tromethamine) compared with Group C (P < 0.05). Cardiac output in Group S was higher at T2-T4 (2, 5, and 10 minutes post-carboprost tromethamine) than in Group C, and at T2-T3 (2 and 5 minutes post-carboprost tromethamine), it was even higher than in Group D (P < 0.05). CONCLUSIONS: Both dexmedetomidine and sufentanil alleviated carboprost tromethamine-induced side effects while maintaining stable hemodynamics. Sufentanil showed greater efficacy in reducing peripheral vascular resistance. CLINICAL TRIAL REGISTRATION: ChiCTR2000038350.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cesarean SectionSufentanilDexmedetomidineCarboprostHumansFemalePregnancyAdultHemodynamics

Substanzen

SufentanilDexmedetomidineCarboprost

Autor:innen und Institutionen

  • Department of Anesthesiology, Chongqing Health Center for Women and Children,, Women and Children's Hospital of Chongqing Medical University, No. 120, Longshan Road, Yubei District, Chongqing, 401147, China.
  • Department of Anesthesiology, Chongqing Health Center for Women and Children,, Women and Children's Hospital of Chongqing Medical University, No. 120, Longshan Road, Yubei District, Chongqing, 401147, China. dodoes@qq.c…

Förderung

  • Institutional Research Grants from Chongqing Health Center for Women and Children
  • Chongqing Traditional Chinese Medicine Research Project (Joint project of Chongqing Health Commission and Science and Technology Bureau
  • National Key Clinical Specialty Discipline Construction Program of China

Zitieren

APA

Li, J., Xiang, B., Lei, X., & Yu, J. (2026). Effectiveness of Dexmedetomidine and Sufentanil in Preventing Adverse Reactions to Carboprost Tromethamine During Cesarean Section with Noninvasive Cardiac System Monitoring. Clinical Drug Investigation. https://doi.org/10.1007/s40261-026-01547-x

Vancouver

Li J, Xiang B, Lei X, Yu J. Effectiveness of Dexmedetomidine and Sufentanil in Preventing Adverse Reactions to Carboprost Tromethamine During Cesarean Section with Noninvasive Cardiac System Monitoring. Clinical Drug Investigation. 2026. doi:10.1007/s40261-026-01547-x

BibTeX
@article{Li2026,
  author = {Li, Jing and Xiang, Bo and Lei, Xiaofeng and Yu, Jin},
  title = {Effectiveness of Dexmedetomidine and Sufentanil in Preventing Adverse Reactions to Carboprost Tromethamine During Cesarean Section with Noninvasive Cardiac System Monitoring},
  journal = {Clinical Drug Investigation},
  year = {2026},
  doi = {10.1007/s40261-026-01547-x}
}
Kostenlos starten →